D
istal ileal disease or ileocolonic disease (L1 and L3 in the Montreal Classification 1 ) represents 2 of the most common phenotypes of Crohn's disease (CD). It is estimated that up to 80% of patients with CD eventually undergo ileocolonic resection for medically refractory disease. 2 However, there is a high rate of recurrence of strictures at the ileocolonic anastomosis (ICA) site. The role of medical therapy for ICA stricture is limited due to its fibrotic nature, precluding the efficacy of currently available medications. Therefore, surgical bowel resection has been the mainstay treatment for those with symptomatic ICA strictures. However, up to 30% of patients with primary ICA could require a second surgery in the area by 10 years. [3] [4] [5] Apart from the risk of postoperative morbidity and mortality, multiple operations predispose these patients to the risk of long-term complications, such as incisional hernia and adhesions, and even short bowel syndrome. Therefore, therapeutic modalities including endoscopic balloon dilation (EBD) have emerged as a valid alternative.
With the advancement of endoscopic technology, through-the-scope balloon dilation has been increasingly performed in the management of various forms of strictures. We have previously shown that EBD was safe and effective in treating ileal pouch stricture after restorative proctocolectomy, 6, 7 primary CD stricture, and ICA strictures. 8 Other investigators have reported that EBD is safe and effective for the treatment of the primary or anastomotic stricture in patients with CD. [9] [10] [11] [12] Nevertheless, EBD of anastomotic strictures may be technically more challenging than in primary CD strictures because of the surgically altered anatomy 13 and ischemic component of the stricture. In addition, EBD can be complicated by perforation and excessive bleeding, although the risk is low. 14 There are no published studies directly assessing the outcomes of EBD and surgery for ICA stricture. 5 The aim of this study was to compare short-term and long-term outcomes between EBD and surgical resection for ICA stricture.
Methods

Patients
Data of EBD became available since 1998 at our institution. A historical cohort of eligible patients with ICA stricture treated with either EBD or surgery between December 1998 and February 2014 were evaluated. Patients who underwent EBD for CD at the Center for Inflammatory Bowel Diseases were identified from an electronic medical record system; those undergoing surgery for CD-related ICA stricture were identified from a prospectively maintained CD database at Department of Colorectal Surgery of the Cleveland Clinic Foundation. The study was approved by the Institutional Review Board at the Cleveland Clinic Foundation.
Inclusion and Exclusion Criteria
Inclusion criteria for the study were patients with CD seen at our inflammatory bowel disease (IBD) center (International Classification of Disease-9-CM code. 555.xx) documented on electronic medical record and having either EBD (CPT code. 45386) for symptomatic ICA stricture documented in our billing database or upfront bowel resection for ICA stricture during the same study period. Colonoscopy report, operative reports, and other medical records were carefully reviewed to confirm the diagnosis and management of all individual ICA strictures.
Patients younger than 18 years of age or having dilations for the primary, nonanastomotic CD strictures were excluded. Patients with concurrent enterocutaneous fistula, abdominal abscess, or other definitive indications for surgical intervention were excluded. Patients with asymptomatic ICA strictures and with surgical stricturoplasty for ICA strictures were excluded. Patients with non-CD ICA strictures were excluded. No patients were included in both EBD and surgery groups.
Demographic and Clinical Variables
Patients' demographic, clinical, endoscopic, histologic, and radiographic data were reviewed and collected. Disease duration was defined as the time interval from the diagnosis of CD to the treatment for ICA stricture. Smoking history was categorized into "never," "current," or "ex-smoker." CD medications were categorized into "anti-tumor necrosis factor biologics," "aminosalicylates," "immunomodulators," "corticosteroids," "antibiotics," or "none." Endoscopy reports were reviewed to extract data on balloon size, use of intralesional steroid injection, technical success, and immediate complications. Pretreatment radiographic reports (computed tomography enterography, magnetic resonance enterography, or contrasted studies) were used to determine the presence of prestenotic proximal bowel dilation.
Telephone contact was performed for those who did not have follow-up data retrievable from the registry after the inception (the first encounter when the patients presented with either follow-up endoscopy or obstructive symptoms). The length of follow-up began on the day of the first dilation or surgery for ICA stricture (ie, the inception point) and continued until the date of the outcome of interest or censoring. Patients with no observed event were censored on the date of their last encounter in the electronic medical records.
Indications and Technique of Endoscopic Balloon Dilation
The decision on whether to perform EBD or surgery first for ICA stricture was at the discretion of the treating IBD specialists and/or colorectal surgeons, based on a combined assessment of clinical presentation, endoscopic, and imaging features. However, EBD could also be performed on ICA strictures incidentally encountered in the course of a routine diagnostic, disease-monitoring, or surveillance colonoscopy at the discretion of the individual endoscopists. Both symptomatic and asymptomatic patients with ICA strictures, if feasible, underwent EBD and those who were asymptomatic were excluded from the current study. Anastomotic or concurrent preanastomotic strictures longer than 4 cm and known fistulizing CD were considered as being not amenable to EBD or as contraindications to EBD in our practice.
The procedure was typically done by IBD specialists or therapeutic endoscopists at our institution. Once the stricture was endoscopically visualized, the throughthe-scope controlled radial expansion dilating balloon was passed through the biopsy channel into the stricture. The balloon diameter ranged between 12 mm and 20 mm. Once in place, the balloon was inflated with water stepwise. The pressure was closely monitored by an endoscopic nurse throughout the procedure. The pressure was maintained for a few (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) seconds, and then the balloon was deflated. The process could be repeated several times during the same procedure until an adequate visualization of the lumen was achieved unless an angulation or narrow stricture prohibited the passage of the pediatric colonoscope. Specific balloon size and endoscopic dilation technique were used at the discretion of the treating endoscopist.
Surgical resection of ICA stricture was generally performed using an open surgical approach. The diseased segment was identified after lysis of adhesion after which the bowel segment containing the stricture was resected. The type of anastomosis performed (stapled vs handsewn) and its configuration (side-to-side, side-to-end, or end-to-end) were left at the discretion of the operating surgeon.
Endoscopic Balloon Dilation or Surgery-Associated Complications
The major complications after EBD were defined as procedure-associated perforation, transfusion-required bleeding, or procedure-associated death. Complications after surgery were identified by chart review and database query including wound infection, postoperative ileus, intra-abdominal/pelvic abscess, anastomotic leak, enterocutaneous fistula, and surgery-associated death.
Outcome Measurements
The primary outcome was the need for the subsequent surgery for the strictured lesion after the intervention. The secondary outcomes were immediate technical success for EBD and postprocedural or postoperative complications. Technical failure was defined as inability to pass the endoscope through the treated stricture after EBD.
Statistical Analysis
Descriptive statistics were computed for all factors. These included means, standard deviations, interquartile range (IQR), and percentiles for continuous variables and frequencies and percentages for categorical factors. Characteristics of anastomotic strictures at the time of the first treatment were compared using Pearson chi-square tests for categorical variables and Wilcoxon rank sum test for continuous factors. The length of follow-up was defined as the interval between the first treatment to the event of interest (surgery) or last follow-up if the patient remained surgery-free. Cox proportional hazard model was used if appropriate. Kaplan-Meier analysis was performed to compare surgery-free survival between EBD and surgical intervention. P < .05 was considered statistically significant. All analyses were performed using R version 3.0.1 (The R Foundation for Statistical Computing, Vienna, Austria).
Results
A total of 307 eligible patients were included. EBD was performed in 176 and surgery in 131 patients.
Comparison of Demographic and Clinical Features
Demographic features were comparable between the 2 groups including age, gender, and race. In univariate analysis, patients undergoing upfront surgery were associated with a higher frequency of being current smokers (58.8% vs 18.8%; P ¼ .0005), the use of corticosteroids or anti-tumor necrosis factor biologics (55.7% vs 36.4%; P ¼ .0007), and multiple previous bowel resections for CD (50.4% vs 36.4%; P ¼ .02) ( Table 1) .
Efficacy of Endoscopic Balloon Dilation
The total number of dilations was 447 with a median of 2 (IQR, [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] per patient in the endoscopy group. During a median follow-up of 1.8 (IQR, 0.4-4.1) years, 91 patients (51.7%) required subsequent surgery for stricture.
The technical failure rate of EBD was 9.7% (17 of 176 patients). Technical failure did not necessarily result in a decision for surgery, depending on the individual circumstances. There were no episodes of bleeding requiring transfusion or deaths associated with EBD.
Procedural or Perioperative Complications
The perforation rate was 1.1% in the EBD group; and the overall postoperative complication rate was 8.8%, including 5 abdominal/pelvic abscess and 4 enterocutaneous fistula in the surgery group. The median length of hospital stay in the surgical group was 5 (IQR, 5-9) days.
Comparison of Outcomes Between Endoscopic Balloon Dilation and Surgery
The median length of follow-up was 1.76 (IQR, 0.38-4.125) years for the EBD group and 4.7 (IQR, 2.2-8.8) years for the surgery group (P < .001). EBD as the initial treatment for ICA stricture was associated with a higher risk for subsequent surgical intervention (logrank P ¼ .002) (Figure 1 ). On Kaplan-Meier analysis, the average time to surgery delayed by dilation was 6.45 years in the endoscopy group.
Risk Factors for the Subsequent Surgical Intervention
A multivariable Cox regression model was performed to assess the risk factors independently associated with the risk of subsequent surgery ( 
Discussion
Our study is the first investigation in the literature to directly compare EBD and surgery for ICA stricture in patients with CD. We demonstrate that the average time to surgery delayed by dilation was 6.45 years in the endoscopy group, suggesting the benefit of EBD in this setting. However, multivariable Cox regression analysis showed that patients undergoing the upfront surgery for ICA stricture had a lower risk for subsequent surgery for CD. This is consistent with the findings of a recent study comparing EBD and surgery for mostly primary structuring CD. 15 In addition, a shorter duration from the CD diagnosis to the inception, a longer interval between the last surgery to the inception, only 1 prior resection, and the presence of concurrent strictures were associated with a higher risk for subsequent surgery.
In patient undergoing ileocolonic resection and ICA for CD, the risk of endoscopic recurrence has been shown to be up to 70% within 12-18 months. 3, 16 As disease progresses, ICA stricture results in a progressively increasing number of patients who develop obstructive symptoms caused by recurrent disease. The benefits of medical therapy in this setting are limited and resection is often required in patients with symptomatic ICA stricture. Strategically placed in between medical and surgical therapy, EBD has emerged as a bridging tool in treating strictures in patients with CD with favorable success rate and efficacy. 9 In a meta-analysis performed by Hassan et al, 12 13 studies were identified and EBD Figure 1 . Risk of subsequent surgery after the initial treatment for ICA stricture (dilation vs surgery). was mainly used for anastomotic strictures. The overall technical success rate was 86%, ranging from 71% to 100%, and 41% of patients required repeated EBD allowing an overall long-term clinical efficacy (avoidance of surgery) rate of 58% during a median follow-up of 33 months. Although complex anastomotic strictures were found to be technically more challenging than de novo or the primary strictures, 13 anastomotic strictures may be associated with better long-term outcomes than de novo strictures. 17 Potential complications associated with EBD include perforation and bleeding, but the risk is low.
14 The perforation rate is less than 5% in most of these studies. 17 Our group has previously shown that EBD seems to be safe and effective in treating primary and secondary stricture in patients with CD with an overall complication rate of 3.1% per patient and 0.93% per procedure. 8 In the present study with only ICA stricture being included, the outcomes and procedure-associated complications seemed to be similar to that of primary CD strictures.
Risk factors associated with the need of subsequent surgery in patients with CD undergoing EBD for stricture have been previously studied with inconsistent results. Technical success of dilation, 12, 18, 19 length of stricture, 10, 12 and nonulcerated stricture 11 were found to be associated with a successful procedure. Smoking and ulcers in the stricture were shown to be prognostic factors of the requirement of surgery in a study by Hoffmann et al. 11 However, the data on the impact of smoking on the EBD outcomes have been controversial. Smoking was associated with a 2-fold increased risk for surgery or repeat dilation in 1 report, 20 whereas others found no impact of smoking. 21 We have recently reported additional risk factors for poor long-term outcomes after EBD including symptomatic disease, longer time interval from last surgery, and radiographic proximal bowel dilation. 22 In a recent study of 138 patients with either primary or anastomotic/secondary stricture, Thienpont et al 9 showed that neither C-reactive protein, medical therapy, nor active disease at the time of dilation affect the need for a second dilation and long-term requirement of surgery. Intralesional steroid injection or the use of biologics was not associated with the need for endoscopic reintervention or surgery for either primary or anastomotic strictures in our previous study. 8 In the current study, we were able to identify significant factors associated with the requirement of surgery on multivariable analysis including shorter duration of CD, longer interval from the last surgery, multiple previous resections, and concurrent stricture. A shorter duration of CD before the first surgery may indicate more aggressive disease behavior, whereas longer duration after preceding surgery suggests that the need for surgery increases over time. These have not been reported in the literature. Further investigation from other institutions is required to test the generalizability of our findings.
Surgery remains the mainstay treatment for patients with CD who develop complications including fistula, stricture, and abscess. Approximately 80% of patients with CD can require at least 1 surgical resection within 10 years of being diagnosed and most of these patients develop recurrence in the first year after operation. 23 Although surgery was found to be associated with a significantly lower risk of subsequent bowel operation, it is not a cure in most patients. In due course, a repeated bowel resection is eventually necessary in most patients. Issues including surgical morbidities, surgical mortality, postoperative adhesions, and short bowel syndrome after multiple abdominal operations may ensue. EBD provides an attractive alternative in this setting by at least postponing surgery.
The present study showed that surgical resection of ICA stricture was associated with a lower risk of subsequent surgery than EBD. However, the bowel preservation is the basic tenet for the treatment of CD, because of the tendency of postoperative recurrence and a higherrisk of procedure-associated complication. 24 However, we showed that EBD spaced out the need for surgery for a significant period of time. The relatively shorter followup for EBD patients than surgery patients (1.8 vs 4.7 years) may have resulted from EBD failures in some patients censored, leading to surgery. Therefore, in patients who potentially require eventual surgery for symptomatic CD stricture, EBD may be attempted first and surgery may serve as a backup. 25 The main disadvantages of EBD are the need of frequent treatments, technical expertise of the endoscopist, and a lower-butstill-existing procedure-associated complication risk. We found that a shorter duration of CD, a longer interval from the last surgery, multiple previous resections, and concurrent stricture were associated with a higher risk for subsequent surgery for ICA stricture. Patients with those risk factors may benefit from the upfront surgical treatment.
The study is limited by its nonrandomized study design. The degree and the length of stricture were not routinely quatified in this study and heterogeneity of patient characteristics is inevitable. The association of anastomosis configuration and EBD could not be assessed because of missing data. The information on clinical decision as to whether EBD or surgery is more appropriate for each individual patient before the patients embarked on the treatment was not available. The potential selection and referral bias may, to a certain degree, compromise the generalizability of the findings. However, surgery was delayed in most of the patients with CD with ICA stricture undergoing EBD and risk factors associated with requirement of subsequent surgery were identified. The practice pattern in the anastomotic stricture in patients with CD varies among tertiary care center, based on local expertise. Patients with symptomatic anastomotic strictures received therapy with either EBD or surgery in our current cohort, with our expertise in endoscopic and surgical management of IBD. This may not be the case in other practices, because some physicians may have a mentality of "watch-and-wait" without giving any therapy.
In conclusion, surgical resection for ICA stricture was associated with a lower risk of further surgery than EBD. However, EBD may space out the need for the second surgery and could be attempted first in those with a lower risk for disease progression. In contrast, patients at risk for recurrent disease may benefit from upfront surgical therapy.
